Many clinical trials today require access to global participant populations, increasing demand for accurate translations and localization of all study documentation.

Overlooking this important step can result in invalid or unusable data, regulatory rejection, and unexpected costs or delays.

This article outlines proactive strategies and considerations that can be addressed before study launch to ensure studies are accurately localized and linguistically validated from end to end.